Untranslated

86-21-64556180

cpd-service@caerulumpharma.com

Home
About Us
Products
Solutions
FAQs
Contact Us

Home
AZD4547

Products Categories

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Hypoglycemic drugs
- DPP-4
- SGLT-1
- SGLT-2
Others
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

AZD4547 - Manufacturers, Factory, Suppliers From China

AZD4547, , , , AZD4547,

Fexagratinib; AZD4547
factory low price DEL-22379 - MSC2530818 ̵...
Well-designed 1092364-38-9 - CAS: 1802253-30-0...
CE Certificate Alpha Cyclodextrin - Revefenaci...
Trending Products Alpha Arbutin - CAS: 1702260...
Good User Reputation for 3 With High Quality &#...
OEM/ODM China Auricularia Auricula Powder - Zy...
Cheapest Price 67-4 – D-methionine - CAS...
China Cheap price AC220 - BAR 502 – Caer...
Low MOQ for Nano Vitamin C - E-7046 – Ca...
China wholesale 6 – Caryophyllene Oxide -...
Wholesale 1 Low Price – Tamoxifen Citrate...
Best-Selling BI847325 - BAY 61-3606 2HCl ̵...
OEM/ODM Supplier Chlormethine Hcl - AZD4547 &#...
Hot New Products High Quality Exemestane Powder...
Reasonable price for Polyvinylpyrrolidone Pvp K...
Factory made hot-sale Diethylstilbestrol 56-53-...

Contact Us

3rd Floor, Building 4, 3918 Daye Road, Fengxian District, Shanghai
86-21-64556180
Within China:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Inquiry

For inquiries about our products, please leave your email with us and we will be in touch within 24 hours.Inquiry

Latest News

AstraZeneca receives regulatory boost for oncology drugs

AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

Top 7 Trends In Pharmaceutical Research In 2018

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

ARS-1620: A promising new inhibitor for KRAS-mutant cancers

ARS-1620: A promising new inhibitor for K...

According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...

AstraZeneca receives regulatory boost for oncology drugs

AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

Top 7 Trends In Pharmaceutical Research In 2018

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

prev

next

FAQs
Downloadable
Contact Us

QR Code

WhatsApp Online Chat !

TOP

Previous Maximize